Okada et al. 2014 measured DNA methylation rates in a CpG island of SLC6A4 in the peripheral blood of fifty Japanese MDD patients before and after six weeks of antidepressant therapy with paroxetine, fluvoxamine, or milnacipran, and in fifty HC [71]. The gene discussed is SLC6A4; the disease is major depressive disorder.